Tactile Medical to Participate in Upcoming Investor Conferences in February and March
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tactile Systems Technology, Inc. (Nasdaq: TCMD) announced participation in two upcoming investor conferences.
Management will engage in a virtual fireside chat on February 17 at 9:30 a.m. ET during the BTIG Virtual MedTech Conference. Additionally, they will present at the Oppenheimer 31st Annual Healthcare Conference on March 16 at 10:40 a.m. ET.
Audio webcasts will be accessible on the company’s investor relations website and available for replay after the events.
Tactile Medical specializes in home therapy devices for chronic diseases, focusing on improving patient care and reducing healthcare costs.
Details
News Market Reaction – TCMD
The recorded move for TCMD in the trading session of this news was -0.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the following upcoming investor conferences:
The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Management will participate in a virtual fireside chat on Wednesday, February 17 at 9:30 a.m. Eastern Time.
The Oppenheimer 31st Annual Healthcare Conference
- Management will present on Tuesday, March 16 at 10:40 a.m. Eastern Time.
Audio webcasts of the presentations will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. The webcasts will be available for replay following the conferences.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.